Which drug is most effective in treating childhood tinea capitis caused by Microsporum species? Trial: Lipozencic J, Skerlev M, Orofino-Costa R, et al, and the Tinea Capitis Study Group. Br J Dermatol 2002; 146: 816-823.

Medical Journal of Australia

Volumn 178, Issue 11, 2003, Pages 577-578

  Commens, Chris ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRISEOFULVIN; PLACEBO; TERBINAFINE;

BODY WEIGHT; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUSTRY; DRUG WITHDRAWAL; FLU LIKE SYNDROME; FOLLOW UP; FUNGUS CULTURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MICROSCOPY; MICROSPORUM; MULTICENTER STUDY; MYCOLOGY; NEUTROPENIA; NONHUMAN; NOTE; OUTCOMES RESEARCH; PARALLEL DESIGN; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STATISTICAL ANALYSIS; TINEA CAPITIS; TREATMENT OUTCOME; TREATMENT PLANNING; URTICARIA;

EID: 0037702958     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05363.x     Document Type: Note

References (5)

1. Hay RJ. Endemic scalp ringworm: An object lesson in control of a common fungal infection. Curr Opin Infect Dis 2001; 14: 121-122.
2. Fuller LC, Smith CH, Cerio R, et al. A randomised comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001; 144: 321-327.
3. Koumantaki E, Kakourou T, Rallis E, et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol 2001; 18: 339-342.
4. Kmietowicz Z. Drug industry is unwilling to run trials in children. BMJ 2000; 320: 1362.
5. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. J Dermatol 2000; 143: 53-58.